These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 9433426)
1. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Chaturvedi N; Sjolie AK; Stephenson JM; Abrahamian H; Keipes M; Castellarin A; Rogulja-Pepeonik Z; Fuller JH Lancet; 1998 Jan; 351(9095):28-31. PubMed ID: 9433426 [TBL] [Abstract][Full Text] [Related]
2. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus]. Sjølie AK; Chaturvedi N; Fuller J Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804 [TBL] [Abstract][Full Text] [Related]
3. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus. Goa KL; Haria M; Wilde MI Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532 [TBL] [Abstract][Full Text] [Related]
4. Systematic review on urine albumin testing for early detection of diabetic complications. Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545 [TBL] [Abstract][Full Text] [Related]
5. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212 [TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242 [TBL] [Abstract][Full Text] [Related]
7. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition. Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP; Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859 [TBL] [Abstract][Full Text] [Related]
8. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy. Sjølie AK; Chaturvedi N J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727 [TBL] [Abstract][Full Text] [Related]
9. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Schalkwijk CG; Chaturvedi N; Twaafhoven H; van Hinsbergh VW; Stehouwer CD; Eur J Clin Invest; 2002 Jul; 32(7):500-6. PubMed ID: 12153550 [TBL] [Abstract][Full Text] [Related]
10. Lack of effect of short-term treatment with amlodipine and lisinopril on retinal autoregulation in normotensive patients with type 1 diabetes and mild diabetic retinopathy. Mehlsen J; Jeppesen P; Erlandsen M; Poulsen PL; Bek T Acta Ophthalmol; 2011 Dec; 89(8):764-8. PubMed ID: 20346089 [TBL] [Abstract][Full Text] [Related]
11. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study. Poulsen PL; Ebbehøj E; Mogensen CE J Intern Med; 2001 May; 249(5):433-40. PubMed ID: 11350567 [TBL] [Abstract][Full Text] [Related]
12. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy. Sørensen VB; Rossing P; Tarnow L; Parving H; Nørgaard T; Kastrup J Clin Sci (Lond); 1998 Dec; 95(6):709-17. PubMed ID: 9831696 [TBL] [Abstract][Full Text] [Related]
13. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II, VEGF, and diabetic retinopathy. Williams B Lancet; 1998 Mar; 351(9105):837-8. PubMed ID: 9519992 [No Abstract] [Full Text] [Related]
15. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II, VEGF, and diabetic retinopathy. Stoschitzky K Lancet; 1998 Mar; 351(9105):836-7. PubMed ID: 9519991 [No Abstract] [Full Text] [Related]
17. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341 [TBL] [Abstract][Full Text] [Related]